Elevance Health, Inc.

ELV

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001659075-26-000002
Filing date: Mar 4, 2026
Earliest execution date: Mar 2, 2026

Summary

Type

Sell

Net shares

+2,225

% of shares

118.73%

Amount (USD)

$49,032

Insider confidence score

91.3 out of 100

Positive

  • Massive buy (≥10% of shares)

Negative

  • Small buy amount (<$50K)

Stock transactions

Transaction 1

Security

Common Stock

Action

Tax_withhold

Date

2026-03-02

Code

F

Net shares

-131.0

Price per Share

$294.07

Amount (USD)

$38,523.17

Acquired/Disposed

Disposed

Shares Owned Before

1,874.0

Shares Owned After

1,743.0

Transaction 2

Security

Common Stock

Action

Grant

Date

2026-03-02

Code

A

Net shares

+426.0

Acquired/Disposed

Acquired

Shares Owned Before

1,743.0

Shares Owned After

2,169.0

Transaction 3

Security

Common Stock

Action

Grant

Date

2026-03-02

Code

A

Net shares

+1,701.0

Acquired/Disposed

Acquired

Shares Owned Before

2,169.0

Shares Owned After

3,870.0

Transaction 4

Security

Common Stock

Action

Grant

Date

2026-03-02

Code

A

Net shares

+266.0

Acquired/Disposed

Acquired

Shares Owned Before

3,870.0

Shares Owned After

4,136.0

Transaction 5

Security

Common Stock

Action

Tax_withhold

Date

2026-03-03

Code

F

Net shares

-37.0

Price per Share

$284.03

Amount (USD)

$10,509.11

Acquired/Disposed

Disposed

Shares Owned Before

4,136.0

Shares Owned After

4,099.0

Derivative Transactions

Transaction 1

Security

Employee Stock Option (Right to Buy)

Action

Grant

Date

2026-03-02

Code

A

Net shares

+1,677.0

Acquired/Disposed

Acquired

Shares Owned Before

0.0

Shares Owned After

1,677.0

Filing's footnotes

1. PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

2. Balance includes 7.06 shares acquired on March 25, 2025, 6.14 shares acquired on June 25, 2025, 7.18 shares acquired on September 25, 2025 and 6.85 shares acquired on December 19, 2025 through a dividend reinvestment plan.

3. Represents restricted share units. Restrictions lapse as follows: 142 shares on 3/2/2027, 3/2/2028 and 3/2/2029.

4. Represents restricted share units. Restrictions lapse as follows: 850 shares on 3/2/2027, and 851 shares on 3/2/2028.

5. Represents performance based restricted share units. Restrictions lapsed on 3/2/2026.

6. The option represents a right to purchase a total of 1,677 shares, and is exercisable in three annual installments, each installment of 559 shares, beginning on 3/2/2027, which is the one-year anniversary of the option grant date.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.